NanoCarrier Co., Ltd.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen (NCT03771820) | NanoCarrier Co., Ltd. | 2019-07-01 |
Track NanoCarrier Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.